$2.48T
Total marketcap
$78.2B
Total volume
BTC 51.91%     ETH 14.29%
Dominance

NewGLAB Pharma CO.,LTD 214870.KQ Stock

1383 KRW {{ price }} 0.000000% {{change_pct}}%
Exchange
KOSDAQ
Market Cap
26.89B KRW
LOW - HIGH [24H]
1383 - 1383 KRW
VOLUME [24H]
0 KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW

NewGLAB Pharma CO.,LTD Price Chart

NewGLAB Pharma CO.,LTD 214870.KQ Financial and Trading Overview

NewGLAB Pharma CO.,LTD stock price 1383 KRW
Previous Close 1383 KRW
Open 0 KRW
Bid 0 KRW x N/A
Ask 0 KRW x N/A
Day's Range 1383 - 1383 KRW
52 Week Range 1383 - 1383 KRW
Volume 0 KRW
Avg. Volume N/A
Market Cap 26.89B KRW
Beta (5Y Monthly) 0.341859
PE Ratio (TTM) N/A
EPS (TTM) 0 KRW
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

214870.KQ Valuation Measures

Enterprise Value 166.02B KRW
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.0118513
Price/Book (mrq) N/A
Enterprise Value/Revenue 6.246
Enterprise Value/EBITDA -7.303

Trading Information

NewGLAB Pharma CO.,LTD Stock Price History

Beta (5Y Monthly) 0.341859
52-Week Change N/A
S&P500 52-Week Change 20.43%
52 Week High 1383 KRW
52 Week Low 1383 KRW
50-Day Moving Average N/A
200-Day Moving Average N/A

214870.KQ Share Statistics

Avg. Volume (3 month) N/A
Avg. Daily Volume (10-Days) N/A
Shares Outstanding 19.45M
Float 26.26M
Short Ratio N/A
% Held by Insiders 9.03%
% Held by Institutions 0.051%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate N/A
Trailing Annual Dividend Yield N/A
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2021
Most Recent Quarter (mrq) September 30, 2022
Next Fiscal Year End December 31, 2022

Profitability

Profit Margin -172.69%
Operating Margin (ttm) -102.59%
Gross Margin 17.26%
EBITDA Margin -85.53%

Management Effectiveness

Return on Assets (ttm) -15.31%
Return on Equity (ttm) -126.062%

Income Statement

Revenue (ttm) 26.58B KRW
Revenue Per Share (ttm) 850.63 KRW
Quarterly Revenue Growth (yoy) 14.29%
Gross Profit (ttm) 3.35B KRW
EBITDA -22734624768 KRW
Net Income Avi to Common (ttm) -45900877824 KRW
Diluted EPS (ttm) N/A
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 15.79B KRW
Total Cash Per Share (mrq) 490.14 KRW
Total Debt (mrq) 47.12B KRW
Total Debt/Equity (mrq) 237.82 KRW
Current Ratio (mrq) 0.704
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) 14.21B KRW
Levered Free Cash Flow (ttm) 40.12B KRW

Profile of NewGLAB Pharma CO.,LTD

Country South Korea
State N/A
City Bucheon-Si
Address HDPro Building
ZIP N/A
Phone 82 3 2683 7903
Website https://newglab.com
Industry
Sector(s)
Full Time Employees 23

NewGLAB Pharma CO.,LTD provides CCTV video security solutions in South Korea and internationally. The company offers network cameras, analog cameras, and ACCs under the HDPRO name, as well as technical support services. It also provides VR solutions; and distributes 5G smart phone accessories and daily supplies, including wireless earphones and vacuum cleaners, ninebots, and toothbrush sterilizers. The company was formerly known as NewGLAB CO.,LTD and changed its name to NewGLAB Pharma CO.,LTD. NewGLAB Pharma CO.,LTD was founded in 2004 and is headquartered in Bucheon, South Korea.

Q&A For NewGLAB Pharma CO.,LTD Stock

What is a current 214870.KQ stock price?

NewGLAB Pharma CO.,LTD 214870.KQ stock price today per share is 1383 KRW.

How to purchase NewGLAB Pharma CO.,LTD stock?

You can buy 214870.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for NewGLAB Pharma CO.,LTD?

The stock symbol or ticker of NewGLAB Pharma CO.,LTD is 214870.KQ.

How many shares does NewGLAB Pharma CO.,LTD have in circulation?

The max supply of NewGLAB Pharma CO.,LTD shares is 19.45M.

What is NewGLAB Pharma CO.,LTD Price to Earnings Ratio (PE Ratio)?

NewGLAB Pharma CO.,LTD PE Ratio is now.

What was NewGLAB Pharma CO.,LTD earnings per share over the trailing 12 months (TTM)?

NewGLAB Pharma CO.,LTD EPS is 0 KRW over the trailing 12 months.